| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 05/22/2002 | EP1206543A2 Membrane associated proteins |
| 05/22/2002 | EP1206542A2 Replication protein a binding transcriptional factor (rbt1) and uses thereof |
| 05/22/2002 | EP1206541A1 Dendritic enriched secreted lymphocyte activation molecule |
| 05/22/2002 | EP1206540A2 Dna sequences isolated from human colonic epithelial cells |
| 05/22/2002 | EP1206539A2 Medicament for the prevention and/or the treatment of ischemic heart and peripheral vascular diseases, tumour and wounds |
| 05/22/2002 | EP1206538A1 Constitutively active stat proteins and their uses for identifying modulators of activity including dysproliferative cellular changes |
| 05/22/2002 | EP1206537A2 Nucleic acids and polypeptides of invertebrate twik channels and methods of use |
| 05/22/2002 | EP1206536A2 HUMAN PROTEINS HAVING HYDROPHOBIC DOMAINS AND DNAs ENCODING THESE PROTEINS |
| 05/22/2002 | EP1206535A1 Tumor-associated antigen (r11) |
| 05/22/2002 | EP1206534A1 Prostate cancer-related gene 3 (pg3) and biallelic markers thereof |
| 05/22/2002 | EP1206533A1 Novel response element |
| 05/22/2002 | EP1206532A2 Improvements in antisense oligomers, delivery of antisense oligomers, and identification of antisense oligomer targets |
| 05/22/2002 | EP1206531A1 A method for preparation of dna from biological material |
| 05/22/2002 | EP1206530A1 Monoclonal antibodies for human cytochrome p450 3a4 and human cytochrome p450 2c9 |
| 05/22/2002 | EP1206529A2 UDP-N-ACETYLGLUCOSAMINE: GALACTOSE-BETA 1,3-N-ACETYLGALACTOSAMINE-ALPHA-R/(GlcNAc to GalNAc) BETA 1,6-N-ACETYLGLUCOSAMINYLTRANSFERASE, C2GnT3 |
| 05/22/2002 | EP1206528A2 Chimeric dna/rna ribozymes containing propanediol |
| 05/22/2002 | EP1206527A1 Treatment of inflammatory or malignant disease using dnazymes |
| 05/22/2002 | EP1206526A2 Subtilisin protease variants having amino acid deletions and substitutions in defined epitope regions |
| 05/22/2002 | EP1206525A2 Method for growing stem cells |
| 05/22/2002 | EP1206495A1 Chimeric polypeptides, method for production and uses thereof |
| 05/22/2002 | EP1206492A2 Self-aligning peptides derived from human elastin and other fibrous proteins |
| 05/22/2002 | EP1206491A1 Tgf-beta receptor polynucleotides, polypeptides, and antibodies |
| 05/22/2002 | EP1206487A2 Notch receptor ligands and uses thereof |
| 05/22/2002 | EP1206483A2 Automated protein purification in the multiwell format by vacuum filtration |
| 05/22/2002 | EP1206479A1 A polynucleotide encoding a human junctional adhesion protein (jam-2) |
| 05/22/2002 | EP1206478A1 Antisense modulation of mekk5 expression |
| 05/22/2002 | EP1206477A1 Cloning of the streptomyces avermitilis genes for glycosylation of avermectin aglycones |
| 05/22/2002 | EP1206285A2 Drug-carrier complexes and methods of use thereof |
| 05/22/2002 | EP1206284A1 Method for delivery of therapeutic agents using a solution of dextrin |
| 05/22/2002 | EP1206267A1 Medicaments that contain xenogenic oligo- or/and polyribonucleotides |
| 05/22/2002 | EP1206233A2 Serine proteases |
| 05/22/2002 | EP1123004B1 Utilization of an antifungal protein from streptomyces tendae against plant pathogenic fungi |
| 05/22/2002 | EP1107996B1 HUMAN ANTI-FACTOR IX/IXa ANTIBODIES |
| 05/22/2002 | EP1057131B1 Methods and apparatus for performing pattern dictionary formation for use in sequence homology detection |
| 05/22/2002 | EP1049487B1 Treatment of acute intermittent porphyria (aip) and other porphyric diseases |
| 05/22/2002 | EP0981648A4 ANTISENSE INHIBITION OF ras GENE WITH CHIMERIC AND ALTERNATING OLIGONUCLEOTIDES |
| 05/22/2002 | EP0929564A4 High level expression of proteins |
| 05/22/2002 | EP0914462A4 Target nucleic acid sequence amplification |
| 05/22/2002 | EP0907890B1 Device for contamination-free delivery and discharge of liquid |
| 05/22/2002 | EP0877937B1 Method of assessing the chemotherapy of hiv-positive patients based on the phenotypic drug sensitivity of the patient's hiv strains |
| 05/22/2002 | EP0842411B1 Apparatus for the parallel alignment of macromolecules, and use thereof |
| 05/22/2002 | EP0726947B1 Insecticidal toxins derived from funnel web (atrax or hadronyche) spiders |
| 05/22/2002 | EP0688366B1 Sensitive nucleic acid sandwich hybridization assays and kits |
| 05/22/2002 | EP0452364B1 Method for preparing water soluble polypeptides |
| 05/22/2002 | EP0437599B1 Cell lineages expressing a biologically active factor ix |
| 05/22/2002 | CN2492562Y Recombination device for substrate mediated membrane protein in lipid bilayer |
| 05/22/2002 | CN1350593A Genotyping kit for diagnosis of human papillomavirus infection |
| 05/22/2002 | CN1350592A Nucleic acid probe-based diagnostic assays for prokaryotic and eukaryotic organisms |
| 05/22/2002 | CN1350591A One step sample preparation and detection of nucleic acids in complex biological samples |
| 05/22/2002 | CN1350590A Method for predicting fiber length using QTL's and molecular markers |
| 05/22/2002 | CN1350587A Acquired resistance genes in plants |
| 05/22/2002 | CN1350586A Process for the fermentative preparation of L-amino acids with amplification of the GND gene |
| 05/22/2002 | CN1350585A i(Neisseria meningitidis) polypeptide BASBO52 |
| 05/22/2002 | CN1350584A Process for producing recombinant insulain from novel fused protein |
| 05/22/2002 | CN1350583A Recombinant platelet collagen receptor Glycoprotein VI and its pharmaceutical use |
| 05/22/2002 | CN1350582A Method for generating split, non-transferable genes that are able to express an active protein product |
| 05/22/2002 | CN1350581A Method for amplifying nucleic acid sequence |
| 05/22/2002 | CN1350580A Method of cel cultivation |
| 05/22/2002 | CN1350579A 葡萄糖脱氢酶 Glucose dehydrogenase |
| 05/22/2002 | CN1350578A Recombinant influenza viruses for vaccines and gene therapy |
| 05/22/2002 | CN1350549A Compositions and methods for generating monoclonal antibodies representative of a specific cell type |
| 05/22/2002 | CN1350546A 结核诊断测验 TB diagnostic test |
| 05/22/2002 | CN1350542A Xylo-LNA analogues |
| 05/22/2002 | CN1350062A Method of identifying production using gene expression |
| 05/22/2002 | CN1350060A Phytase gene and its cloning |
| 05/22/2002 | CN1350058A Method of breeding strain for soaking ore |
| 05/22/2002 | CN1350003A Human hyaloid band B cell epitose fusogenic peptide and its production process |
| 05/22/2002 | CN1349827A Human tumor necrosis factor-alpha oral prepn. of marine polychlorella |
| 05/22/2002 | CN1085249C production of variant nisin |
| 05/22/2002 | CN1085248C Molecular marking method for seedless grape breeding |
| 05/22/2002 | CN1085041C Animal ceratin transgenic cotton fibre and its gene engineering method |
| 05/22/2002 | CA2343422A1 Dna profile storage |
| 05/21/2002 | US6392126 Nucleotide sequence coding enzymatic polypeptide; for use as diagnostic tool in genetic engineering |
| 05/21/2002 | US6392125 Method for producing the transformants of coffee plants and transgenic coffee plants |
| 05/21/2002 | US6392124 Infectious vectors and clones of plants derived from the turnip mosaic virus (TUMV) |
| 05/21/2002 | US6392123 Regulatory sequences for use in the generation of preferential sex sterility in plants; for generation hybrid seeds |
| 05/21/2002 | US6392122 Apple promoters for expression of transgenes in plants |
| 05/21/2002 | US6392121 Expression vector for use in generating heterologous proteins in plants |
| 05/21/2002 | US6392120 Modification of starch biosynthetic enzyme gene expression to produce starches in grain crops |
| 05/21/2002 | US6392119 Genetically engineered plant for use biological pest control and cancer therapy |
| 05/21/2002 | US6392118 Stable cultures; for controlling cell distribution within artificial organ |
| 05/21/2002 | US6392030 Strawberry promoters and genes |
| 05/21/2002 | US6392029 HIV chemokines |
| 05/21/2002 | US6392028 Functional DNA clone for hepatitis C virus (HCV) and uses thereof |
| 05/21/2002 | US6392027 Mammalian adrenocorticotropic hormone receptor nucleic acids |
| 05/21/2002 | US6392026 Binding domains from plasmodium vivax and plasmodium falciparum erythrocyte binding proteins |
| 05/21/2002 | US6392025 Human NHE3 protein and non-human cells expressing same |
| 05/21/2002 | US6392024 Nucleotide sequences coding freeze resistant polypeptide; for use in food processing and organ transplants |
| 05/21/2002 | US6392023 Nucleotide sequences which codes preferential polypeptide for use in serodiagnostics and vaccine development |
| 05/21/2002 | US6392022 Gene originating in human chondrocyte |
| 05/21/2002 | US6392020 Monoclonal antibody to the clonotypic structure of a T-cell receptor, a pharmaceutical compostion and a diagnostic reagent comprising the same |
| 05/21/2002 | US6392018 Polypeptides for use in the treatment of pathologies associated with inflammatory respone, nervous system disorders and leukemias; for use as a molecular weight control; for use in foods |
| 05/21/2002 | US6392017 Parasitic helminth DiAg2 proteins and uses thereof |
| 05/21/2002 | US6392016 Preferential polypeptide for use in the diagnosis and treatment of tumors; antiproliferative agents |
| 05/21/2002 | US6392014 Cloning of gene encoding the GP28.5 protein of Toxoplasma gondii; peptide fragments of said protein and their applications |
| 05/21/2002 | US6391858 Gene delivery in various muscle cell types; gene therapy for expression of erythropoietin to treat blood disorders such as anemias, for example |
| 05/21/2002 | US6391853 Human tissue inhibitor of metalloproteinase-4 |
| 05/21/2002 | US6391852 Methods and compositions for diagnosis and treatment of iron overload diseases and iron deficiency diseases |
| 05/21/2002 | US6391847 Modulating transcription |
| 05/21/2002 | US6391655 Oxidized styrenic polymers for DNA binding |